219 related articles for article (PubMed ID: 27756605)
1. Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice.
Zhou F; Zhang Y; Chen J; Hu X; Xu Y
Eur J Pharmacol; 2016 Nov; 791():735-740. PubMed ID: 27756605
[TBL] [Abstract][Full Text] [Related]
2. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
4. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
Du ZA; Sun MN; Hu ZS
Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
[TBL] [Abstract][Full Text] [Related]
5. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
6. Casticin inhibits lipopolysaccharide-induced acute lung injury in mice.
Wang C; Zeng L; Zhang T; Liu J; Wang W
Eur J Pharmacol; 2016 Oct; 789():172-178. PubMed ID: 27450485
[TBL] [Abstract][Full Text] [Related]
7. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
Zhang A; Wang S; Zhang J; Wu H
Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
10. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
[TBL] [Abstract][Full Text] [Related]
11. Atractylodin attenuates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome and TLR4 pathways.
Tang F; Fan K; Wang K; Bian C
J Pharmacol Sci; 2018 Apr; 136(4):203-211. PubMed ID: 29551284
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of chlorogenic acid reducing lipopolysaccharide
Liu C; Cheng X; Sun J; Zhang S; Zhang Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):280-288. PubMed ID: 35545320
[TBL] [Abstract][Full Text] [Related]
14. Diesel Exhaust Particulates Enhances Susceptibility of LPS-Induced Acute Lung Injury through Upregulation of the IL-17 Cytokine-Derived TGF-β
Kim DI; Song MK; Lee K
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33419073
[TBL] [Abstract][Full Text] [Related]
15. [The effect of recombinant interleukin-10/Fc fusion protein on lipopolysaccharide-induced acute lung injury in mice].
Bi MH; Wang BE; Zheng XX; Li M; Mayer K; Zhang SW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):461-4. PubMed ID: 18687171
[TBL] [Abstract][Full Text] [Related]
16. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
Lu Y; Yu T; Liu J; Gu L
PLoS One; 2018; 13(4):e0196405. PubMed ID: 29694408
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways.
Tian L; Li W; Wang T
Microb Pathog; 2017 Jul; 108():104-108. PubMed ID: 28483599
[TBL] [Abstract][Full Text] [Related]
18. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of total glucosides of White Paeony Capsules in ameliorating acute lung injury based on NLRP3 inflammasome].
Xu YJ; Wang XL; Mu WQ; Wen JC; Wang Y; Xiu Y; Dong X; Li JJ; Zhan XY; Xiao XH; Bai ZF
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2754-2765. PubMed ID: 38812176
[TBL] [Abstract][Full Text] [Related]
20. Nano-chemically Modified Tetracycline-3 (nCMT-3) Attenuates Acute Lung Injury via Blocking sTREM-1 Release and NLRP3 Inflammasome Activation.
Meng Q; Wang X; Guo D; Shi C; Gu R; Ma J; Nieman G; Kollisch-Singule M; Luo J; Cooney RN
Shock; 2022 May; 57(5):749-758. PubMed ID: 35583915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
